PCVX icon

Vaxcyte
PCVX

Upgrade to unlock
Buy
Hold
Sell

2 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$62
24% upside
High target

2 analyst ratings

positive
1  neutral
50%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
BTIG
BTIG
Thomas Shrader
50% 1-yr PCVX win rate
10 Nov ‘25 20 days ago
Goldman Sachs
Goldman Sachs
Asad Haider
12 Sep ‘25 2 months ago